RESOURCES

Social Media Influencers: #headsup, the FTC Has Its Eye on You
May 26, 2017 | 2:21 PM

  By Stacy Ehrlich On April 19, 2017, the Federal Trade Commission (FTC) sent letters to over 90 marketers and so-called “influencers,” reminding them that…

VIEW MORE
KKB Partners Author FDLI Chapter on Philip Morris USA Inc. v. FDA
May 21, 2017 | 11:58 AM

The Food and Drug Law Institute recently published the latest annual installment of its popular "top cases" publication, Top Food and Drug Cases, 2016 & Cases to…

VIEW MORE
Jacqueline Chan Authors FDLI Chapter on Significant Settlements
May 21, 2017 | 11:49 AM

The Food and Drug Law Institute recently published the latest annual installment of its popular "top cases" publication, Top Food and Drug Cases, 2016 & Cases to…

VIEW MORE
KKB PARTNER SUZAN ONEL INVITED TO BE KEYNOTE SPEAKER IN U.S. EMBASSY SPONSORED CONFERENCE IN HONDURAS
May 16, 2017 | 3:02 PM

KKB is pleased to announce that the U.S. State Department has invited KKB partner Suzan Onel to be the keynote speaker at a regional conference…

VIEW MORE
Are Changes on the Horizon for Homeopathic Drugs? Navigating the Regulatory Landscape as FDA and FTC Waters Get Choppier
April 21, 2017 | 3:56 PM

By Celeste D. Wheeler FDA’s recent aggressive enforcement action against homeopathic teething tablets and gels brings into sharp focus the dilemma facing manufacturers of homeopathic…

VIEW MORE
Off-Label Communications and Intended Use: What’s Happening Now?
March 23, 2017 | 4:56 PM

By:  Cynthia L. Meyer This week, the U.S. Food and Drug Administration (“FDA” or “Agency”) announced it is further delaying by one year the effective…

VIEW MORE
KKB Partners Present VTA Webinar on E-Liquid Ingredient Listings
February 11, 2017 | 2:47 PM

On February 8, 2017, KKB partners Stacy Ehrlich and Will Woodlee presented a webinar on FDA ingredient listing submissions for e-liquid products.  Hosted by the Vapor…

VIEW MORE
KKB Partner Tony Young Participates in Podcast on Dietary Supplement GMP Inspections
February 5, 2017 | 4:34 PM

As FDA has gained more experience with inspections for good manufacturing practices (GMPs) for dietary supplements, its processes have become more sophisticated.  The agency knows which…

VIEW MORE
21st Century Cures Act Provides (Some) Clarity on FDA’s Regulation of Software
January 31, 2017 | 3:37 PM

By: Suzan Onel[*] On December 13, 2016, President Obama signed the 21st Century Cures Act (Public Law No. 114-255) (“the Act”) into law.  This sweeping…

VIEW MORE
Leading Medical Device and Food Law Expert Suzan Onel Joins Kleinfeld, Kaplan & Becker, LLP, as Partner
November 11, 2016 | 3:06 PM

Kleinfeld, Kaplan & Becker, LLP, (KKB) announced today that Suzan Onel has joined the firm as a partner.  KKB is a Washington, D.C., boutique law…

VIEW MORE